Education
About Us
Working with TipRanks
Follow Us
JSMD - ETF AI Analysis
Top Page
Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD)
Rating:72Outperform
Price Target:―
Positive Factors
Broad Sector Diversification
The fund spreads its investments across many sectors, including technology, health care, industrials, consumer, and financials, which helps reduce the impact if any one area struggles.
Strong Recent Performance
The ETF has shown steady gains over the past month, three months, and year-to-date, indicating positive recent momentum.
Solid Top Holdings Contribution
Several of the largest positions, such as Comfort Systems, Onto Innovation, Rocket Lab, and Argan, have delivered strong year-to-date results that support the fund’s overall performance.
Negative Factors
High U.S. Concentration
Almost all of the fund’s assets are invested in U.S. companies, offering very little geographic diversification if the U.S. market weakens.
Growth and Small/Mid-Cap Volatility
Because the ETF focuses on small- and mid-sized growth companies, its share price can be more sensitive to market swings than funds holding larger, more established firms.
Moderate Expense Ratio
The fund’s expense ratio is not especially low, meaning fees take a noticeable, though not extreme, bite out of long-term returns compared with the cheapest ETFs.
JSMD vs. SPDR S&P 500 ETF (SPY)
AUM854.03M
RegionNorth America
Expense Ratio0.30%
Beta1.01
IssuerJanus Henderson
Inception DateFeb 23, 2016
Dividend Yield0.51%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume53,434
30 Day Avg. Volume58,741
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
99.81Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering119
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
JSMD Summary
JSMD is the Janus Henderson Small/Mid Cap Growth Alpha ETF, focused on U.S. small and mid-sized companies with strong growth potential rather than tracking a specific index. It invests across many sectors, with a tilt toward technology, health care, and industrials. Well-known holdings include Jabil and Rocket Lab USA. Someone might invest in JSMD to seek long-term growth and diversify beyond large, well-known blue-chip stocks. A key risk is that smaller growth companies can be more volatile, so the ETF’s price can rise and fall more sharply than the overall market.
How much will it cost me?The Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD) has an expense ratio of 0.3%, which means you’ll pay $3 per year for every $1,000 invested. This is slightly higher than the average for ETFs because it is actively managed, focusing on selecting small and mid-sized companies with growth potential. Active management typically involves more research and decision-making, which can increase costs.
What would affect this ETF?JSMD's focus on small and mid-cap growth companies in sectors like technology, industrials, and healthcare positions it to benefit from innovation and economic expansion in the U.S. However, it could face challenges from rising interest rates, which may impact growth stocks, and economic slowdowns that disproportionately affect smaller companies. Regulatory changes or sector-specific disruptions could also influence its performance.
JSMD Top 10 Holdings
JSMD leans into U.S. small and mid-cap growth, with a clear tilt toward tech and industrial innovators. Comfort Systems is doing the heavy lifting, rising steadily and giving the fund a strong industrial backbone, while Onto Innovation and Fabrinet add a powerful tech-driven tailwind after a strong run. Consumer name Tapestry has also been climbing, helping on the cyclical side. On the flip side, Medpace has been lagging lately, acting as a bit of a speed bump. Overall, performance is being driven by a handful of rising U.S. growth stories.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Comfort Systems | 4.28% | $36.77M | $46.54B | 301.71% | 80 Outperform | |
| Somnigroup International | 2.06% | $17.68M | $18.92B | 44.08% | 72 Outperform | |
| Onto Innovation | 1.98% | $17.03M | $10.78B | 35.71% | 82 Outperform | |
| Ryman | 1.78% | $15.26M | $6.43B | 6.51% | 66 Neutral | |
| Jabil | 1.76% | $15.13M | $27.51B | 66.71% | 73 Outperform | |
| Argan | 1.72% | $14.78M | $5.75B | 227.48% | 73 Outperform | |
| InterDigital | 1.65% | $14.16M | $9.29B | 69.58% | 76 Outperform | |
| Medpace Holdings | 1.62% | $13.91M | $12.66B | 33.38% | 79 Outperform | |
| Tapestry | 1.54% | $13.25M | $31.38B | 85.71% | 69 Neutral | |
| Fabrinet | 1.54% | $13.23M | $18.12B | 146.12% | 78 Outperform |
JSMD Technical Analysis
Positive
―
Price Trends
85.06
Positive
83.87
Positive
81.18
Positive
Market Momentum
0.12
Positive
51.87
Neutral
48.47
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For JSMD, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 85.95, equal to the 50-day MA of 85.06, and equal to the 200-day MA of 81.18, indicating a bullish trend. The MACD of 0.12 indicates Positive momentum. The RSI at 51.87 is Neutral, neither overbought nor oversold. The STOCH value of 48.47 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JSMD.
JSMD Peer Comparison
Comparison Results
Performance Comparison
JSMD
Janus Henderson Small/Mid Cap Growth Alpha ETF
86.06
13.08
17.92%
MSSM
Morgan Stanley Pathway Small-Mid Cap Equity ETF
―
―
―
RSMC
Rockefeller U.S. Small-Mid Cap ETF
―
―
―
CSMD
Congress SMid Growth ETF
―
―
―
GRNJ
Fundstrat Granny Shots US Small- & Mid-Cap ETF
―
―
―
NBSM
Neuberger Berman Small-Mid Cap ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents